Regeneus Ltd First Patient Treated in Progenza Stem Cell Trial for Knee Osteoarthritis

Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced that the first patient has been enrolled and treated in the STEP (Safety, Tolerability and Efficacy of Progenza) trial, the first clinical trial of Progenza, the company’s …

[Read the full article here]

Comments are closed.